Evidence map›Paper›PMID 41074710›Full record

ArticleClinical and translational medicine2025

Decidualised endometrial stromal cell-derived extracellular vesicles induce bystander decidualisation and cAMP-mediated attenuation of natural killer cell cytotoxicity.

Maryam Mousavi, Negar Vanaki, Kayhan Zarnani, Zahra Aghazadeh, Soheila Arefi, Jila Abedi-Asl, Fazel Shokri, Seyed-Alireza Razavi, Amir-Hassan Zarnani

Abstract read
In one paragraph

Article in Clinical and translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Maryam MousaviDepartment of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0009-0001-7923-3709
Negar VanakiDepartment of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Kayhan ZarnaniDepartment of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Zahra AghazadehDepartment of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Soheila ArefiReproductive Biotechnology Research Center, Avicenna Research Institute, Academic Center for Education, Culture and Research, Tehran, Iran.
Jila Abedi-AslReproductive Biotechnology Research Center, Avicenna Research Institute, Academic Center for Education, Culture and Research, Tehran, Iran.
Fazel ShokriDepartment of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Seyed-Alireza RazaviDepartment of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Amir-Hassan ZarnaniDepartment of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

Funding

Iranian Council for the Development of Regenerative Medicine and Stem Cell Technologies 11/104553Tehran University of Medical Sciences 1401-1-99-57053
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41074710
PMCPMC12514555

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.